Amplitude Surgical SAS (AMPLI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has a cash flow conversion efficiency ratio of 0.029x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.77 Million ≈ $3.24 Million USD) by net assets (€94.70 Million ≈ $110.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check AMPLI strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Amplitude Surgical SAS - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. See shareholders equity of Amplitude Surgical SAS for net asset value and shareholders' equity analysis.
Amplitude Surgical SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amplitude Surgical SAS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Y.U.D. Yangtze River Investment Industry Co Ltd
SHG:600119
|
-0.060x |
|
Palladyne AI Corp
NASDAQ:PDYN
|
-0.114x |
|
Innovative Solutions and Support
NASDAQ:ISSC
|
0.119x |
|
Socar Inc.
KO:403550
|
-0.170x |
|
Colonial Coal International Corp
V:CAD
|
-0.023x |
|
Galaxy Far East
TWO:6227
|
-0.118x |
|
Editas Medicine Inc
NASDAQ:EDIT
|
-5.232x |
|
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
|
-0.103x |
Annual Cash Flow Conversion Efficiency for Amplitude Surgical SAS (2011–2024)
The table below shows the annual cash flow conversion efficiency of Amplitude Surgical SAS from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Amplitude Surgical SAS worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | €95.82 Million ≈ $112.02 Million |
€4.04 Million ≈ $4.73 Million |
0.042x | -50.07% |
| 2023-06-30 | €95.81 Million ≈ $112.02 Million |
€8.10 Million ≈ $9.47 Million |
0.084x | -44.36% |
| 2022-06-30 | €52.57 Million ≈ $61.46 Million |
€7.98 Million ≈ $9.33 Million |
0.152x | +268.42% |
| 2021-06-30 | €56.87 Million ≈ $66.48 Million |
€2.34 Million ≈ $2.74 Million |
0.041x | -76.40% |
| 2020-06-30 | €70.91 Million ≈ $82.90 Million |
€12.38 Million ≈ $14.48 Million |
0.175x | +81.15% |
| 2019-06-30 | €85.50 Million ≈ $99.95 Million |
€8.24 Million ≈ $9.64 Million |
0.096x | +1.63% |
| 2018-06-30 | €94.68 Million ≈ $110.69 Million |
€8.98 Million ≈ $10.50 Million |
0.095x | +265.03% |
| 2017-06-30 | €103.14 Million ≈ $120.58 Million |
€2.68 Million ≈ $3.13 Million |
0.026x | +54.47% |
| 2016-06-30 | €118.12 Million ≈ $138.09 Million |
€1.99 Million ≈ $2.32 Million |
0.017x | +112.09% |
| 2015-06-30 | €118.76 Million ≈ $138.84 Million |
€-16.53 Million ≈ $-19.33 Million |
-0.139x | -59.01% |
| 2014-06-30 | €22.31 Million ≈ $26.08 Million |
€-1.95 Million ≈ $-2.28 Million |
-0.088x | -1008.15% |
| 2013-06-30 | €20.44 Million ≈ $23.89 Million |
€197.00K ≈ $230.31K |
0.010x | +106.61% |
| 2012-06-30 | €22.40 Million ≈ $26.18 Million |
€-3.26 Million ≈ $-3.82 Million |
-0.146x | -8.89% |
| 2011-06-30 | €25.40 Million ≈ $29.69 Million |
€-3.40 Million ≈ $-3.97 Million |
-0.134x | -- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more